A Pilot Study of Choline and Betaine Supplementation in Arsenic-exposed Individuals in Bangladesh
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Urinary arsenic metabolites
8 weeks after the start of the intervention
No
Megan N Hall, ScD
Principal Investigator
Columbia University
United States: Food and Drug Administration
AAAJ1959
NCT01749982
January 2013
August 2013
Name | Location |
---|